Barriers to Reducing Hemodialysis Time and Frequency in Patients with Residual Kidney Function

被引:4
|
作者
Meyer, Timothy W. [1 ,2 ]
Blanco, Ignacio J. [1 ,2 ]
Grimm, John C. [1 ,2 ]
Leypoldt, John K. [3 ]
Sirich, Tammy L. [1 ,2 ]
机构
[1] Stanford Univ, Dept Med, Stanford, CA 94305 USA
[2] Vet Affairs Palo Alto Hlth Care Syst, Dept Med, Palo Alto, CA USA
[3] Nalecz Inst Biocybernet & Biomed Engn PAS, Warsaw, Poland
来源
基金
美国国家卫生研究院;
关键词
UREA; DIALYSIS;
D O I
10.1681/ASN.2021030361
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Having residual kidney function should lessen the requirement for hemodialysis. If the kidney still removes waste solutes to some extent, less dialysis is necessary to limit their accumulation in the body. A well-reasoned case has been made for reducing the intensity of dialysis in patients with residual function, particularly in those initiating dialysis.1,2 However, major barriers hinder reducing hemodialysis time, frequency, or both for patientswith residual kidney function. © 2021 by the American Society of Nephrology.
引用
收藏
页码:2112 / 2116
页数:5
相关论文
共 50 条
  • [41] Association of Parameters of Mineral Bone Disorder with Mortality in Patients on Hemodialysis according to Level of Residual Kidney Function
    Wang, Mengjing
    Obi, Yoshitsugu
    Streja, Elani
    Rhee, Connie M.
    Lau, Wei Ling
    Chen, Jing
    Hao, Chuanming
    Hamano, Takayuki
    Kovesdy, Csaba P.
    Kalantar-Zadeh, Kamyar
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 12 (07): : 1118 - 1127
  • [42] Association of Initial Twice-Weekly Hemodialysis Treatment with Preservation of Residual Kidney Function in ESRD Patients
    Zhang, Minmin
    Wang, Mengjing
    Li, Haiming
    Yu, Ping
    Yuan, Li
    Hao, Chuanming
    Chen, Jing
    Kalantar-Zadeh, Kamyar
    AMERICAN JOURNAL OF NEPHROLOGY, 2014, 40 (02) : 140 - 150
  • [43] Use of small doses of furosemide in chronic kidney disease patients with residual renal function undergoing hemodialysis
    Helton P. Lemes
    Salustiano Araujo
    Daniella Nascimento
    Danny Cunha
    Cesar Garcia
    Vinicius Queiroz
    Sebastião R. Ferreira-Filho
    Clinical and Experimental Nephrology, 2011, 15 : 554 - 559
  • [44] Use of small doses of furosemide in chronic kidney disease patients with residual renal function undergoing hemodialysis
    Lemes, Helton P.
    Araujo, Salustiano
    Nascimento, Daniella
    Cunha, Danny
    Garcia, Cesar
    Queiroz, Vinicius
    Ferreira-Filho, Sebastiao R.
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2011, 15 (04) : 554 - 559
  • [45] Residual kidney function at one-year in diabetic and nondiabetic incident patients treated with incremental hemodialysis
    Saudan, Patrick
    Jaques, David
    Ponte, Belk
    Dufey, Anne
    Haidar, Fadi
    De Seigneux, Sophie
    SWISS MEDICAL WEEKLY, 2023, 153 : 9S - 9S
  • [46] Predicting residual kidney function in hemodialysis patients using serum β-trace protein and β2-microglobulin
    Wong, Jonathan
    Sridharan, Sivakumar
    Berdeprado, Jocelyn
    Vilar, Enric
    Viljoen, Adie
    Wellsted, David
    Farrington, Ken
    KIDNEY INTERNATIONAL, 2016, 89 (05) : 1090 - 1098
  • [47] The importance of residual kidney function in haemodialysis patients
    Kong, Jessica
    Davies, Matthew
    Mount, Peter
    NEPHROLOGY, 2018, 23 (12) : 1073 - 1080
  • [48] Individualized Hemodialysis Treatment: A Perspective on Residual Kidney Function and Precision Medicine in Nephrology
    Hur, Inkyong
    Lee, Yong Kyu
    Kalantar-Zadeh, Kamyar
    Obi, Yoshitsugu
    CARDIORENAL MEDICINE, 2019, 9 (02) : 69 - 82
  • [49] Residual Kidney Function in Hemodialysis: Its Importance and Contribution to Improved Patient Outcomes
    Obi, Yoshitsugu
    Raimann, Jochen G.
    Kalantar-Zadeh, Kamyar
    Murea, Mariana
    TOXINS, 2024, 16 (07)
  • [50] Evaluation of Residual Kidney Function during Once-Weekly Incremental Hemodialysis
    Bolasco, Piergiorgio
    Casula, Laura
    Contu, Rita
    Cadeddu, Mariella
    Murtas, Stefano
    BLOOD PURIFICATION, 2021, 50 (02) : 246 - 253